Bolivia, Plurinational State of vs Malaysia: Access to anti-retroviral drugs, male
Bolivia, Plurinational State of
59.0%
in 2024
Malaysia
59.0%
in 2024
Bolivia, Plurinational State of rank
105th
Malaysia rank
105th
Access to anti-retroviral drugs, male over time
- Bolivia, Plurinational State of
- Malaysia
How they compare
Bolivia, Plurinational State of currently reports 59.0% against 59.0% in Malaysia, a difference of 0.0%.
Across all 25 years both countries report, Malaysia has been ahead every year.
Bolivia, Plurinational State of ranks 105th and Malaysia ranks 105th of 141 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.5% | 7.2% | 5.7% | Malaysia |
| 2010s | 19.0% | 29.7% | 10.7% | Malaysia |
| 2020s | 51.4% | 55.6% | 4.2% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bolivia, Plurinational State of or Malaysia?
- Bolivia, Plurinational State of, at 59.0% against 59.0% in Malaysia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bolivia, Plurinational State of and Malaysia?
- 0.0%, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Malaysia?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia, Plurinational State of and Malaysia rank globally for access to anti-retroviral drugs, male?
- Bolivia, Plurinational State of ranks 105th and Malaysia ranks 105th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.